SLC6A1 and epilepsy with myoclonic atonic seizures: As portrayed in our recent review (Fischer et al., 2022), numerous mutations have been identified in the human SLC6A1 (GAT-1) gene in patient cohorts manifesting myoclonic-atonic epilepsy (MAE/myoclonic-astatic epilepsy/Doose syndrome) (Carvill et al., 2015; Johannesen et al., 2018; Mattison et al., 2018).